Recently, by modeling CLL transformation into RT through in vivo gene editing of only 6 loss-of-function driver genes, it has been reported that only TP53, the MYC negative regulator MGA and the chromatin remodeler CHD2 promoted RT [42]. This evidence concerns the gene MYC and B-cell chronic lymphocytic leukemia.